• "One of the nation's premier plaintiffs' firms."

    American Lawyer
  • "Representing the best qualities of the plaintiffs' bar."

    The National Law Journal
  • "Their effective and caring advocacy for clients has earned Lieff Cabraser its first-class reputation."

    The Daily Journal
  • NLJ Hot List icon
  • Lieff Cabraser: follow us on (social media links)

    Visit us on Facebook
    Follow us on Twitter
    View our YouTube channel
    Read our LinkedIn profile
    Read our Tumblr
    Visit us on Google+

Case Center

Blood Factor

  • Issue: Contaminated blood products
  • Result: Confidential settlements

Blood Factor VIII and Factor IX Litigation

Working with counsel in Asia, Europe, Central and South America and the Middle East, Lieff Cabraser represented over 1500 of hemophiliacs worldwide, or their survivors and estates, who contracted HIV and/or Hepatitis C (HCV), and Americans with hemophilia who contracted HCV, from contaminated and defective blood factor products produced by American pharmaceutical companies. In 2004, Lieff Cabraser was appointed Plaintiffs’ Lead Counsel of the “second generation” Blood Factor MDL litigation presided over by Judge Grady in the Northern District of Illinois. The case reached a global settlement in 2009.

Personal Injury Brochure